These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 19136659)
1. SHIP limits immunoregulatory capacity in the T-cell compartment. Collazo MM; Wood D; Paraiso KH; Lund E; Engelman RW; Le CT; Stauch D; Kotsch K; Kerr WG Blood; 2009 Mar; 113(13):2934-44. PubMed ID: 19136659 [TBL] [Abstract][Full Text] [Related]
2. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease. Biagi E; Di Biaso I; Leoni V; Gaipa G; Rossi V; Bugarin C; Renoldi G; Parma M; Balduzzi A; Perseghin P; Biondi A Transplantation; 2007 Jul; 84(1):31-9. PubMed ID: 17627234 [TBL] [Abstract][Full Text] [Related]
3. Host natural killer T cells induce an interleukin-4-dependent expansion of donor CD4+CD25+Foxp3+ T regulatory cells that protects against graft-versus-host disease. Pillai AB; George TI; Dutt S; Strober S Blood; 2009 Apr; 113(18):4458-67. PubMed ID: 19221040 [TBL] [Abstract][Full Text] [Related]
4. Regulatory dendritic cells protect against cutaneous chronic graft-versus-host disease mediated through CD4+CD25+Foxp3+ regulatory T cells. Fujita S; Sato Y; Sato K; Eizumi K; Fukaya T; Kubo M; Yamashita N; Sato K Blood; 2007 Nov; 110(10):3793-803. PubMed ID: 17687106 [TBL] [Abstract][Full Text] [Related]
5. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts. Giorgini A; Noble A J Leukoc Biol; 2007 Nov; 82(5):1053-61. PubMed ID: 17684039 [TBL] [Abstract][Full Text] [Related]
6. Increased numbers and suppressive activity of regulatory CD25(+)CD4(+) T lymphocytes in the absence of CD4 engagement by MHC class II molecules. Shen X; Niu C; König R Cell Immunol; 2013 Apr; 282(2):117-28. PubMed ID: 23770721 [TBL] [Abstract][Full Text] [Related]
8. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection. Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253 [TBL] [Abstract][Full Text] [Related]
9. Donor Requirements for Regulatory T Cell Suppression of Murine Graft-versus-Host Disease. Pierini A; Colonna L; Alvarez M; Schneidawind D; Nishikii H; Baker J; Pan Y; Florek M; Kim BS; Negrin RS J Immunol; 2015 Jul; 195(1):347-55. PubMed ID: 25994967 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of graft-versus-host disease by double-negative regulatory T cells. Young KJ; DuTemple B; Phillips MJ; Zhang L J Immunol; 2003 Jul; 171(1):134-41. PubMed ID: 12816991 [TBL] [Abstract][Full Text] [Related]
11. Role of STAT3 in CD4+CD25+FOXP3+ regulatory lymphocyte generation: implications in graft-versus-host disease and antitumor immunity. Pallandre JR; Brillard E; Créhange G; Radlovic A; Remy-Martin JP; Saas P; Rohrlich PS; Pivot X; Ling X; Tiberghien P; Borg C J Immunol; 2007 Dec; 179(11):7593-604. PubMed ID: 18025205 [TBL] [Abstract][Full Text] [Related]
12. Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+CD25+ and Foxp3-CD25- CD4+ regulatory T cells. Sun JB; Raghavan S; Sjöling A; Lundin S; Holmgren J J Immunol; 2006 Dec; 177(11):7634-44. PubMed ID: 17114433 [TBL] [Abstract][Full Text] [Related]
14. CD4+ invariant natural killer T cells protect from murine GVHD lethality through expansion of donor CD4+CD25+FoxP3+ regulatory T cells. Schneidawind D; Pierini A; Alvarez M; Pan Y; Baker J; Buechele C; Luong RH; Meyer EH; Negrin RS Blood; 2014 Nov; 124(22):3320-8. PubMed ID: 25293774 [TBL] [Abstract][Full Text] [Related]
15. Suppression of alloimmunity in mice by regulatory T cells converted with conditioned media. Teng L; Liu L; Su Y; Yuan X; Li J; Fu Q; Chen S; Wang C J Surg Res; 2011 Dec; 171(2):797-806. PubMed ID: 20538297 [TBL] [Abstract][Full Text] [Related]
16. DR3 signaling modulates the function of Foxp3+ regulatory T cells and the severity of acute graft-versus-host disease. Nishikii H; Kim BS; Yokoyama Y; Chen Y; Baker J; Pierini A; Alvarez M; Mavers M; Maas-Bauer K; Pan Y; Chiba S; Negrin RS Blood; 2016 Dec; 128(24):2846-2858. PubMed ID: 27760760 [TBL] [Abstract][Full Text] [Related]
17. Induction and role of regulatory CD4+CD25+ T cells in tolerance to the transgene product following hepatic in vivo gene transfer. Cao O; Dobrzynski E; Wang L; Nayak S; Mingle B; Terhorst C; Herzog RW Blood; 2007 Aug; 110(4):1132-40. PubMed ID: 17438084 [TBL] [Abstract][Full Text] [Related]
18. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity. Tsang J; Jiang S; Tanriver Y; Leung E; Lombardi G; Lechler RI Int Immunopharmacol; 2006 Dec; 6(13-14):1883-8. PubMed ID: 17161341 [TBL] [Abstract][Full Text] [Related]
19. Allogeneic bone marrow grafts with high levels of CD4(+) CD25(+) FoxP3(+) T cells can lead to engraftment failure. Fricke S; Rothe K; Hilger N; Ackermann M; Oelkrug C; Fricke C; Schönfelder U; Niederwieser D; Emmrich F; Sack U Cytometry A; 2012 Jun; 81(6):476-88. PubMed ID: 22522779 [TBL] [Abstract][Full Text] [Related]
20. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro. Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]